Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON47137
NL-OMON47137
Completed
Not Applicable

Investigating a digital device to increase the efficiency of trauma-focused psychotherapy in PTSD patients: a pilot randomized controlled trial of the EMD app. - Addition of the EMD app in PTSD treatment

Academisch Medisch Centrum0 sites57 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsposttraumatic stress disorderPTSD10002861

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
posttraumatic stress disorder
Sponsor
Academisch Medisch Centrum
Enrollment
57
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

Trial is onging in other countries

Registry
who.int
Start Date
TBD
End Date
June 30, 2020
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\- 18 \* 65 years of age or older
  • •\- Referred to a mental health care organisation for PTSD following one or more traumatic experiences
  • •\- Meet the DSM\-5 diagnostic criteria for PTSD as confirmed by the CAPS\-5
  • •\- Are in possession of a device such as a laptop, tablet, mobile phone or computer
  • •\- Have sufficient command of the Dutch language, both verbally and in writing
  • •\- Provide signed informed consent

Exclusion Criteria

  • •\- Having current high risk for suicide according to the M.I.N.I. Interview for psychiatric disorders, section C
  • •\- Having serious psychiatric co\-morbidity i.e. bipolar affective disorder, psychotic disorder, substance dependence that would interfere with EMDR treatment as assessed by the therapist in the intake.
  • •\- Being unable to comprehend the spoken and written Dutch language.
  • •\- Not having access to a computer, laptop, tablet or smartphone with an internet connection.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Evaluation of a Novel Diagnostic Kit for the Detection of Placental Alpha-Microglobulin-1 in the Prediction of Preterm Birth in Women Presenting With Signs and Symptoms of Preterm Laborpre term labor (PTL)threatening early birth10026908
NL-OMON46986HAGAMEDICAL B.V.110
Withheld
Not Applicable
[Trial of device that is not approved or cleared by the U.S. FDA]Retinal Disease
NCT03964831[Redacted]40
Withheld
Not Applicable
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT02719444[Redacted]
Withheld
Not Applicable
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT01464580[Redacted]
Withheld
Not Applicable
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT04296773[Redacted]